Polycystic Ovary Syndrome and Risks for COVID-19 Infection: A Comprehensive Review

    February 2022 in “ Reviews in Endocrine and Metabolic Disorders ”
    Sebastião Freitas de Medeiros, Márcia Marly Winck Yamamoto, Matheus Antônio Souto de Medeiros, Ana Karine Lin Winck Yamamoto, Bruna Barcelo Barbosa
    Image of study
    TLDR Women with PCOS have a higher risk of severe COVID-19 due to related health issues.
    The review examined the link between polycystic ovary syndrome (PCOS) and increased risks for COVID-19 infection, finding that women with PCOS were at a 28%-50% higher risk of contracting COVID-19 and experiencing severe outcomes. This heightened risk was attributed to common PCOS comorbidities such as obesity, insulin resistance, hyperandrogenism, and chronic inflammation, which could exacerbate COVID-19 severity. A UK study of over 21,000 PCOS patients supported these findings. The review suggested that hyperandrogenism might facilitate viral entry, while obesity and insulin resistance contributed to immune dysfunction. It emphasized the need for careful management of these comorbidities and specific care protocols for PCOS patients to mitigate COVID-19 risks.
    Discuss this study in the Community →

    Research cited in this study

    17 / 17 results

    Related Community Posts Join

    6 / 21 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 1 year ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Sugar and Hair loss connections

      in Research/Science  41 upvotes 7 months ago
      High sugar diets may worsen hair loss by increasing 5α-reductase activity and androgen levels, especially in women with PCOS. A low sugar diet might reduce scalp DHT levels, similar to finasteride, but genetics also significantly influence hair loss.

      community C’est terrible - at my wits end

      in Female  450 upvotes 2 years ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

    Related Research

    4 / 4 results